DRUG · Unmapped registry intervention
Buntanetap/Posiphen
Find medicine records ·
Find other trials using this name
Clinical trial
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
NCT05686044
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2, PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Alzheimer Diseaseverified · MONDO: Alzheimer disease
Interventions
PlaceboDRUG
Sponsors & collaborators
Annovis Bio Inc.lead sponsor
Mapped research locations
MiamiFlorida, United States6SyracuseNew York, United States2Winter ParkFlorida, United States2HoustonTexas, United States1TampaFlorida, United States1DurhamNorth Carolina, United States1IndianapolisIndiana, United States1PhoenixArizona, United States1SpokaneWashington, United States1HonoluluHawaii, United States1DecaturGeorgia, United States1HollywoodFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05686044 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.